In recent decades, the development of new stable organic radicals has become a topic for extensive investigations1,2 because of their unique optical,3 electronic,4 and magnetic5 properties. Most organic radicals are unstable under ambient conditions and dimerize6 quickly-to form new covalent bonds—or become oxidized/reduced under ambient conditions, making their isolation and characterization demanding tasks. In general, there are several common strategies for enhancing the air-stability of organic radicals, such as (i) increasing the steric hindrance around the radical center7 in order to prevent dimerization, (ii) introducing electron-withdrawing groups to lower the LUMO energy level8 in order to enhance resistance to oxidation by O2 and H2O, and (iii) recovering aromaticity9, amidst other exmaples1. However, due to the difficulty in stabilizing organic radicals, new compositions and methods are needed.
Disclosed herein are compositions comprising air-stable radical [2]catenanes and methods of making the same. One aspect of the invention includes compositions comprising a [2]catenane. The [2]catenane comprises a first ring mechanically interlocked with a second ring or a salt thereof. In some embodiments, the [2]catenane is an air-stable bisradical hexacationic state, an air-stable monoradical heptacationic state, or the mixture of both states. In some embodiment, the first ring, the second ring, or both the first ring and the second ring are mCBPQT. In a particular embodiment, both the first ring and the second ring are mCBPQT. In another embodiment, only one of the first ring and the second ring are mCBPQT.
The compositions described herein may have positive reduction potentials. Suitably, the composition has an Ered1 greater than +0.50 V versus Ag/AgCl and/or the composition has an Ered2 greater than +0.25 V versus Ag/AgCl.
The composition described herein may have a near infrared absorption band longer than 1200 nm. Suitably, the near infrared absorption band longer than 1400 nm, 1600 nm, or 1800 nm.
Another aspect of the invention includes crystalline composition. The crystalline composition may comprises any of the compositions described herein and have a molecular packing arranging defined by a triclinic, space group P1-(no. 2) or a orthorhombic, space group Pna21 (no. 33). In one embodiment, the composition has a molecular packing arranging defined by the triclinic, space group P1-(no. 2) and lattice parameters of a= 14.1 ± 0.1 Å, b = 15.3 ± 0.1 Å, c = 23.3 ± 0.1 Å, α = 84.6 ± 0.1°, β = 82.2 ± 0.1°, and γ = 66.5 ± 0.1°. In another embodiment, the composition has a molecular packing arranging defined by the orthorhombic, space group Pna21 (no. 33) and lattice parameters of a = 27.2 ± 0.1 Å, b = 20.4 ± 0.1 Å, and c = 16.7 ± 0.1 Å. Suitably, the composition may comprise six counter anions for every [2]catenane.
Near infrared dyes, memory devices, or energy storage materials may be prepared from any of the compositions described herein.
Yet another aspect of the invention is methods for preparing [2]catenanes. The method may comprise contacting a cationic ring with a cationic guest molecule in the presence of reducing agents, i.e., Cu dust, Zu dust, or CoCp2, etc., thereby reducing the cationic ring and the cationic guest molecule and forming a radical cationic inclusion complex and reacting the guest molecule of the radical cationic inclusion complex with a ring-closing reagent to prepare the [2]catenane or reaching the termini of the guest molecule of the radical cationic inclusion complex with each other to prepare the [2]catenane. In some embodiments, the method further comprises reducing the [2]catenane with reducing agent to prepare a reduced [2]catenane. In some embodiments, the cationic ring is mCBPQT4+. In one embodiment, the cationic guest molecule may be
In another embodiment, the cationic guest molecule may be
Suitably, the ring-closing reagent may be 4,4′-bipyridine.
These and other aspects of the invention will be described herein.
Non-limiting embodiments of the present invention will be described by way of example with reference to the accompanying figures, which are schematic and are not intended to be drawn to scale. In the figures, each identical or nearly identical component illustrated is typically represented by a single numeral. For purposes of clarity, not every component is labeled in every figure, nor is every component of each embodiment of the invention shown where illustration is not necessary to allow those of ordinary skill in the art to understand the invention.
Disclosed herein are [2]catenane compositions that allow for air-stable organic radicals. The protection afforded the [2]catenanes by mechanical bonds allow for the remarkable stability of these radicals.
Catenanes are organic compounds having two or more macrocyclic rings connected in the manner of links in a chain, without a covalent bond. Macrocycles are a cyclic macromolecular or a macromolecular cyclic portion of a macromolecule. A molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass. As demonstrated in the Examples that follow, the catenanes are [2]catenanes having two mechanically interlocked rings that result in air-stable radicals, such as bis- and mono-radicals. Suitably, an “air-stable” radical is a radical stable in air for at least 1 hour, 1 day, 1 week, or more. In some embodiments, the air-stable radical is a radical in a bisradical hexacationic state, a monoradical heptacationic state, or a mixture of both states.
The first ring and the second ring of the catenane each comprise an alternating cyclic arrangement of unsubstituted or substituted 4,4′-bipyridinium (BIPY) and phenylene subunits. An exemplary BIPY subunit is a subunit of Formula I,
As disclosed in the examples that follow, the BIPY subunit comprises unsubstituted pyridine groups. Derivatives of the unsubstituted BIPY subunit may be prepared and used to form the catenane compositions described herein by replacing any of the hydrogens on either or both of the pyridine rings with one or more substituents. Exemplary substituents R1 and R2 include, but are not limited to, —CH3, —OH, —NH2, —SH, —CN, —NO2, —F, —Cl, —Br, —I moieties. R1 and R2 may be independently selected. In some instances, R1 and R2 are the same. In other instances, R1 and R2 are the different. Because BIPY subunits are threaded through the opposite macrocyclic ring, the substituents on a threaded BIPY subunit must be small enough to allow threading. The second ring may further comprise an additional BIPY subunit that is not threaded through the macrocycle of the opposite ring. Because the additional BIPY subunit is not threaded, substituents such as C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, C1-C12 carboxy, C1-C12 carbonyl, C1-C12 aldehyde, or C1-C12 alkoxy moieties having too much steric bulk to allow threading may also be used for this subunit. In some embodiments, the substituents comprise C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 carboxy, C1-C6 carbonyl, C1-C6 aldehyde, or C1-C6 alkoxy moieties or C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 carboxy, C1-C4 carbonyl, C1-C4 aldehyde, or C1-C4 alkoxy moieties.
When a ring comprises two BIPY subunits, the BIPY subunits can be the same or different. Both BIPY units may be unsubstituted, one BIPY subunit may be unsubstituted and the other substituted, or both BIPY subunits may be substituted. When both BIPY subunits are substituted, the BIPY subunits may comprise the same or different substituents.
The BIPY subunits may access a number of different redox states, including as a BIPY2+ dication or as a BIPY•+ radical cation. Formula I may represent the BIPY2+, BIPY•+, or BIPY0 redox state depending on context. Moreover, when a ring comprises two BIPY subunits, the subunits may be in the same redox state or different redox states. 4,4′-Bipyridinium radical cations (BIPY•+) tend to form (BIPY•+)2 dimers in a ‘face-to-face’ manner in the solid state as a result of favorable radical-pairing interactions. Conversely, in a dilute solution, (BIPY•+)2 dimers are prone to dissociate because of their low association constants.
The BIPY subunits are linked by phenylene subunits, such as meta-phenylene and/or para-phenylene subunits that may optionally have one or more linkers for joining the BIPY subunits to the phenylene subunits. As disclosed in the examples that follow, the phenylene subunits are unsubstituted. Derivatives of the unsubstituted para-phenylene and/or meta-phenylene subunit may be prepared and used to form the catenane compositions described herein by replacing any of the hydrogens on the phenylene with one or more substituents. Because the phenylene subunits may be threaded through the opposite macrocyclic ring to prepare the catenane, the substituents on a threaded phenylene subunit must be small enough to allow threading. Exemplary substituents include, but are not limited to, alkyl, alkenyl, alkynyl, carboxy, carbonyl, aldehyde, alkoxy, —OH, —NH2, —SH, —CN, —NO2, —N3, —F, —Cl, —Br, —I moieties. In some embodiments, the substituent is -R,-OR, —NH2, -COOR, —CN, —N3, —CH═CHR, —NO2, —F, —Cl, —Br, —I moieties where R is an alkyl, such as a C1-C12 alkyl, C1-C6 alkyl, or C1-C4 alkyl.
In some embodiments, the BIPY subunits are linked through a para-xylylene and/or a meta-xylylene subunits where the methylenes of the xylylene are linkers for joining the BIPY subunits to the phenylene subunits. The xylylene subunits may be substituted. Exemplary substituents for the xylylene subunit include, but are not limited to, alkyl, alkenyl, alkynyl, carboxy, carbonyl, aldehyde, alkoxy, —OH, —NH2, —SH, —CN, —NO2, —F, —Cl, —Br, —I moieties. In some embodiments, the substituent is -R,-OR, —NH2, -COOR, —CN, —N3, —CH═CHR, —NO2, —F, —Cl, —Br, —I moieties where R is an alkyl, such as a C1-C12 alkyl, C1-C6 alkyl, or C1-C4 alkyl.
An exemplary embodiment of one or both of the rings of the [2]catenane is mCBPQT,
Derivatives may also be prepared by substituting any of the hydrogens on any of the aromatic rings of the BIPY subunit as described above. The m- and p-xylylene subunits may be similarly substituted as described above.
Another exemplary embodiment of one of the rings of the [2]catenane is CBPQT,
Derivatives may also be prepared by substituting any of the hydrogens on any of the aromatic rings of the BIPY subunit as described above. The p-xylylene subunits may be similarly substituted as described above.
In an embodiment of the invention, the [2]catenane composition comprises two mechanically interlocked mCBPQT. This [2]catenane may be referred to as mHo[2]C.
In an embodiment of the invention, the [2]catenane composition comprises one mechanically interlocked mCBPQT and one mechanically interlocked CBPQT. This [2]catenane may be referred to as mHe[2]C.
The mechanically interlocked compositions may be prepared by providing a radical cationic inclusion complex and preforming a ring-closing reaction. The present methods uses Cu dust to prepare the inclusion complexes, but other reducing agents may also be used. Prior methods for preparing inclusion complexes used Zn dust, however Zn dust must be removed before performing the ring-closing reaction as will over-reduce radical cation, preparing a neutral state, if it remains in the reaction mixture. The advantage of using Cu dust is that it can remain in the reaction mixture with no threat of over-reduction, and can reduce continuously the newly formed radical cations.
The method for preparing a [2]catenane may comprise contracting a cationic ring with a cationic guest molecule in the presence of reducing agent, such as Cu dust. The presence of the Cu dust reduces the cationic ring and the cationic guest molecule into radical cations, respectively. In an embodiment, the cationic ring is mCBPQT4+ but any of the rings described herein may be employed.
Scheme 1 illustrates two embodiments for preparing the [2]catenane. In a first embodiments, the guest molecule of the radical cationic inclusion complex is reacted with a ring-closing reagent to prepare the [2]catenane. In an alternative embodiment, the termini of the guest molecule of the radical cationic inclusion complex may be reacted with each other to prepare the [2]catenane.
Scheme 1. Synthetic route for the preparation of mHe[2]C·6PF6, mHo[2]C·6PF6, mHe[2]C·8PF6 and mHo[2]C·8PF6.
As evidenced by two highly charged [2]catenanes, air-stable singlet bisradicals may be prepared and isolated. mHe[2]C•6PF6 and mHo[2]C•6PF6 that were synthesized by exploiting radical host-guest templation between BIPY•+ derivatives and mCBPQT2(•+). In contrast to other [2]catenanes that have been isolated as air-stable monoradicals, both mHe[2]C•6PF6 and mHo[2]C•6PF6, exist as air-stable singlet bisradicals as evidenced by both X-ray crystallography in the solid state and EPR spectroscopy in solution. Electrochemical studies indicate that the first two reduction peaks of these two [2]catenanes are shifted significantly to more positive potentials, a feature which is responsible for their extraordinary stability in air. The mixed-valence nature of the mono- and bisradical states endows them with unique NIR-absorption properties, e.g., NIR absorption bands for the mono- and bisradical states observed at ∼1800 and ∼1450 nm, respectively. These [2]catenanes are useful in applications that include NIR photothermal conversion, UV/Vis/NIR multiple-state electrochromic materials, and multiple-state memory devices. Our findings highlight the principle of “mechanical-bond-induced-stabilization” as an efficient strategy for designing persistent organic radicals.
N,N′-Disubstituted-4,4′-bipyridinium dications (BIPY2+), also known as viologens10, are electron acceptors that can undergo two sequential and reversible one-electron reductions with half-wave potentials of -0.30 and -0.71 V (versus Ag/AgCl in MeCN). The bipyridinium radical cation (BIPY•+), which is generated from the one-electron reduction of BIPY2+, is a well-known thermally stable radical species in an inert atmosphere, and can undergo (noncovalent) π-dimerization11 on account of radical-radical interactions; such interactions have been exploited intensively in supramolecular chemistry12 and mechanostereochemistry13. Although, BIPY•+ cannot undergo σ-dimerization to form a covalent bond, it is unstable when exposed to air because the BIPY2+/BIPY•+ reduction potential (-0.30 V versus Ag/AgCl) is not sufficiently positive for the radicals to resist aerobic oxidation. One way to tune the reduction potential of viologens towards more positive values involves introducing electron-withdrawing substituents onto viologen derivatives that makes them more electron-deficient, as exemplified (
Cyclobis(paraquat-p-phenylene) bisradical dication CBPQT2(•+), shown in
mCBPQT2(•+) also associates with MV•+ in MeCN, despite its cavity being significantly smaller (
As used herein, an asterick “*” or a plus sign “+” may be used to designate the point of attachment for any radical group or substituent group.
The term “alkyl” as contemplated herein includes a straight-chain or branched alkyl radical in all of its isomeric forms, such as a straight or branched group of 1-12, 1-10, or 1-6 carbon atoms, referred to herein as C1-C12 alkyl, C1-C10-alkyl, and C1-C6-alkyl, respectively.
The term “alkylene” refers to a diradical of an alkyl group. An exemplary alkylene group is —CH2CH2—.
The term “haloalkyl” refers to an alkyl group that is substituted with at least one halogen. For example, —CH2F, —CHF2, —CF3, —CH2CF3, —CF2CF3, and the like
The term “heteroalkyl” as used herein refers to an “alkyl” group in which at least one carbon atom has been replaced with a heteroatom (e.g., an O, N, or S atom). One type of heteroalkyl group is an “alkoxyl” group
The term “alkenyl” as used herein refers to an unsaturated straight or branched hydrocarbon having at least one carbon-carbon double bond, such as a straight or branched group of 2-12, 2-10, or 2-6 carbon atoms, referred to herein as C2-C12-alkenyl, C2-C10-alkenyl, and C2-C6-alkenyl, respectively
The term “alkynyl” as used herein refers to an unsaturated straight or branched hydrocarbon having at least one carbon-carbon triple bond, such as a straight or branched group of 2-12, 2-10, or 2-6 carbon atoms, referred to herein as C2-C12-alkynyl, C2-C10-alkynyl, and C2-C6-alkynyl, respectively
The term “cycloalkyl” refers to a monovalent saturated cyclic, bicyclic, or bridged cyclic (e.g., adamantyl) hydrocarbon group of 3-12, 3-8, 4-8, or 4-6 carbons, referred to herein, e.g., as “C4-8-cycloalkyl,” derived from a cycloalkane. Unless specified otherwise, cycloalkyl groups are optionally substituted at one or more ring positions with, for example, alkanoyl, alkoxy, alkyl, haloalkyl, alkenyl, alkynyl, amido, amidino, amino, aryl, arylalkyl, azido, carbamate, carbonate, carboxy, cyano, cycloalkyl, ester, ether, formyl, halogen, haloalkyl, heteroaryl, heterocyclyl, hydroxyl, imino, ketone, nitro, phosphate, phosphonato, phosphinato, sulfate, sulfide, sulfonamido, sulfonyl or thiocarbonyl. In certain embodiments, the cycloalkyl group is not substituted, i.e., it is unsubstituted.
The term “cycloalkylene” refers to a diradical of an cycloalkyl group.
The term “partially unsaturated carbocyclyl” refers to a monovalent cyclic hydrocarbon that contains at least one double bond between ring atoms where at least one ring of the carbocyclyl is not aromatic. The partially unsaturated carbocyclyl may be characterized according to the number oring carbon atoms. For example, the partially unsaturated carbocyclyl may contain 5-14, 5-12, 5-8, or 5-6 ring carbon atoms, and accordingly be referred to as a 5-14, 5-12, 5-8, or 5-6 membered partially unsaturated carbocyclyl, respectively. The partially unsaturated carbocyclyl may be in the form of a monocyclic carbocycle, bicyclic carbocycle, tricyclic carbocycle, bridged carbocycle, spirocyclic carbocycle, or other carbocyclic ring system. Exemplary partially unsaturated carbocyclyl groups include cycloalkenyl groups and bicyclic carbocyclyl groups that are partially unsaturated. Unless specified otherwise, partially unsaturated carbocyclyl groups are optionally substituted at one or more ring positions with, for example, alkanoyl, alkoxy, alkyl, haloalkyl, alkenyl, alkynyl, amido, amidino, amino, aryl, arylalkyl, azido, carbamate, carbonate, carboxy, cyano, cycloalkyl, ester, ether, formyl, halogen, haloalkyl, heteroaryl, heterocyclyl, hydroxyl, imino, ketone, nitro, phosphate, phosphonato, phosphinato, sulfate, sulfide, sulfonamido, sulfonyl or thiocarbonyl. In certain embodiments, the partially unsaturated carbocyclyl is not substituted, i.e., it is unsubstituted.
The term “aryl” is art-recognized and refers to a carbocyclic aromatic group. Representative aryl groups include phenyl, naphthyl, anthracenyl, and the like. The term “aryl” includes polycyclic ring systems having two or more carbocyclic rings in which two or more carbons are common to two adjoining rings (the rings are “fused rings”) wherein at least one of the rings is aromatic and, e.g., the other ring(s) may be cycloalkyls, cycloalkenyls, cycloalkynyls, and/or aryls. Unless specified otherwise, the aromatic ring may be substituted at one or more ring positions with, for example, halogen, azide, alkyl, aralkyl, alkenyl, alkynyl, cycloalkyl, hydroxyl, alkoxyl, amino, nitro, sulfhydryl, imino, amido, carboxylic acid, -C(O)alkyl, -CO2alkyl, carbonyl, carboxyl, alkylthio, sulfonyl, sulfonamido, sulfonamide, ketone, aldehyde, ester, heterocyclyl, aryl or heteroaryl moieties, —CF3, —CN, or the like. In certain embodiments, the aromatic ring is substituted at one or more ring positions with halogen, alkyl, hydroxyl, or alkoxyl. In certain other embodiments, the aromatic ring is not substituted, i.e., it is unsubstituted. In certain embodiments, the aryl group is a 6-10 membered ring structure.
The terms “heterocyclyl” and “heterocyclic group” are art-recognized and refer to saturated, partially unsaturated, or aromatic 3- to 10-membered ring structures, alternatively 3-to 7-membered rings, whose ring structures include one to four heteroatoms, such as nitrogen, oxygen, and sulfur. The number of ring atoms in the heterocyclyl group can be specified using 5 Cx-Cx nomenclature where x is an integer specifying the number of ring atoms. For example, a C3-C7 heterocyclyl group refers to a saturated or partially unsaturated 3- to 7-membered ring structure containing one to four heteroatoms, such as nitrogen, oxygen, and sulfur. The designation “C3-C7” indicates that the heterocyclic ring contains a total of from 3 to 7 ring atoms, inclusive of any heteroatoms that occupy a ring atom position.
The terms “amine” and “amino” are art-recognized and refer to both unsubstituted and substituted amines, wherein substituents may include, for example, alkyl, cycloalkyl, heterocyclyl, alkenyl, and aryl.
The terms “alkoxyl” or “alkoxy” are art-recognized and refer to an alkyl group, as defined above, having an oxygen radical attached thereto. Representative alkoxyl groups include methoxy, ethoxy, tert-butoxy and the like.
An “ether” is two hydrocarbons covalently linked by an oxygen. Accordingly, the substituent of an alkyl that renders that alkyl an ether is or resembles an alkoxyl, such as may be represented by one of —O—alkyl, —O—alkenyl, —O—alkynyl, and the like.
An “epoxide” is a cyclic ether with a three-atom ring typically include two carbon atoms and whose shape approximates an isosceles triangle. Epoxides can be formed by oxidation of a double bound where the carbon atoms of the double bond form an epoxide with an oxygen atom.
The term “carbonyl” as used herein refers to the radical —C(O)—.
The term “carboxamido” as used herein refers to the radical —C(O)NRR′, where R and R′ may be the same or different. Rand R′ may be independently alkyl, aryl, arylalkyl, cycloalkyl, formyl, haloalkyl, heteroaryl, or heterocyclyl.
The term “carboxy” as used herein refers to the radical -COOH or its corresponding salts, e.g. —COONa, etc.
The term “amide” or “amido” as used herein refers to a radical of the form —R1C(O)N(R2)—, —R1C(O)N(R2)R3—, —C(O)NR2R3, or —C(O)NH2, wherein R1, R2 and R3 are each independently alkoxy, alkyl, alkenyl, alkynyl, amide, amino, aryl, arylalkyl, carbamate, cycloalkyl, ester, ether, formyl, halogen, haloalkyl, heteroaryl, heterocyclyl, hydrogen, hydroxyl, ketone, or nitro.
Unless otherwise specified or indicated by context, the terms “a”, “an”, and “the” mean “one or more.” For example, “a molecule” should be interpreted to mean “one or more molecules.”
As used herein, “about”, “approximately,” “substantially,” and “significantly” will be understood by persons of ordinary skill in the art and will vary to some extent on the context in which they are used. If there are uses of the term which are not clear to persons of ordinary skill in the art given the context in which it is used, “about” and “approximately” will mean plus or minus ≤10% of the particular term and “substantially” and “significantly” will mean plus or minus >10% of the particular term.
As used herein, the terms “include” and “including” have the same meaning as the terms “comprise” and “comprising.” The terms “comprise” and “comprising” should be interpreted as being “open” transitional terms that permit the inclusion of additional components further to those components recited in the claims. The terms “consist” and “consisting of” should be interpreted as being “closed” transitional terms that do not permit the inclusion additional components other than the components recited in the claims. The term “consisting essentially of” should be interpreted to be partially closed and allowing the inclusion only of additional components that do not fundamentally alter the nature of the claimed subject matter.
All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein, is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the invention.
All references, including publications, patent applications, and patents, cited herein are hereby incorporated by reference to the same extent as if each reference were individually and specifically indicated to be incorporated by reference and were set forth in its entirety herein.
Preferred aspects of this invention are described herein, including the best mode known to the inventors for carrying out the invention. Variations of those preferred aspects may become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventors expect a person having ordinary skill in the art to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than as specifically described herein. Accordingly, this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.
All reagents were purchased from commercial suppliers and used without further purification. Compounds 1•2PF6, CBPQT•4PF6, mCBPQT•4PF6 were preparedS1 according to literature procedures. Thin layer chromatography (TLC) was performed on silica gel 60 F254 (E. Merck). Column chromatography was carried out on silica gel 60F (Merck 9385, 0.040-0.063 mm). C-18 Columns were used for analytical and preparative reverse-phase high-performance liquid-chromatography (RP-HPLC) on Agilent 1260 infinity LC equipped with Agilent 6120 LC/MS electrospray system and Shimadzu Prominence LC-8a instruments, respectively, eluted with H2O/MeCN (0.1 % v/v TFA) and monitored using a UV detector (λ = 360 nm). UV/Vis Spectra were recorded at room temperature on a Shimadzu UV-3600 spectrophotometer. Nuclear magnetic resonance (NMR) spectra are recorded on Agilent DD2 500 as well as on Bruker Avance III 400 and 500 spectrometers, with working frequencies of 400 and 500 MHz for 1H, as well as 100 and 125 MHz for 13 C nuclei, respectively. Chemical shifts were reported in ppm relative to the signals corresponding to the residual non-deuterated solvents (CD3CN: δH =1.94 ppm and δC = 118.26 ppm for 13CN). High-resolution mass spectra (HR-ESI) were measured on a Finnigan LCQ iontrap mass spectrometer. Electron paramagnetic resonance (EPR) measurements at X-band (9.5 GHz) were performed with a Bruker Elexsys E580, equipped with a 4122SHQE resonator. All samples were prepared in an Argon-filled atmosphere. Scans were performed with magnetic field modulation amplitude of 1 G and non-saturating microwave power between 0.4 and 0.6 mW. Samples were contained in quartz tubes with I.D. 1.50 mm and O.D. 1.80 mm and sealed with a clear ridged UV curin epoxy (IllumaBond 60-7160RCL) and used immediately after preparation. Cyclic voltammetry (CV) and differential pulse voltammetry (DPV) experiments were carried out at room temperature in Argon-purged MeCN solutions with a Gamry Multipurpose instrument (Reference 600) interfaced to a PC. CV Experiments were performed using a glassy carbon working electrode (0.071 cm2). The electrode surface was polished routinely with 0.05 µm alumina-water slurry on a felt surface immediately before use. The counter electrode was a Pt coil and the reference electrode was Ag/AgCl electrode. The concentration of the supporting electrolyte tetrabutylammonium hexafluorophosphate (NH4PF6) was 0.1 M.
The highly stable bisradical [2]catenanes, mHe[2]C•6PF6 and mHo[2]C·6PF6, were synthesized by modifying the previously reported procedure16b for the preparation of Ho[2]C•7PF6 The mCBPQT•4PF6 host and the guest molecule 1•2PF6 were reduced (Scheme 1) with an excess of Cu dust in MeCN in a N2-filled glovebox for 2 h, producing the trisradical tricationic inclusion complex 1•+⊂mCBPQT2(•+). 4,4′-Bipyridine was then added to this solution so as to react with 1•2PF6 and give mHe[2]C3•5+ as the ring-closure product, which was then reduced again by the Cu dust to give mHe[2]C4(•+). The reaction mixture was stirred at room temperature under N2 for 1 week, after which it was exposed to air. Purification by reverse phase column chromatography, followed by counterion exchange, and recrystallization (see Section B) afforded mHe[2]C•6PF6 in 30% yield.
In a similar manner, mHo[2]C•6PF6 was obtained in 19% yield by reacting mCBPQT•4PF6 with 2•3PF6 using the same protocol. The lower yield of mHo[2]C•6PF6 can be attributed to the smaller cavity of mCBPQT2(+•) compared to that of CBPQT2(+•), which renders the ring-closure step for mHo[2]C•6PF6 more difficult than that for mHe[2]C•6PF6. High resolution electrospray ionization mass spectrometry (ESI-MS) confirmed that both catenanes possess the same molecular formula, i.e., C72H64F36N8P6.
1H NMR Spectra have been recorded for both catenanes in their fully oxidized states— namely, mHe[2]C·8PF6 and mHo[2]C·8PF6 —which were obtained by oxidizing the as-synthesized catenanes with an excess of NOPF6. Because of their lower symmetries, both mHe[2]C·8PF6 and mHo[2]C·8PF6 display much more complicated 1H NMR spectra than that observed for Ho[2]C·8PF6. The characteristic signals of these [2]catenanes correspond to the proton resonances of the innermost BIPY2+ units, which are strongly shielded and consequently shifted dramatically upfield, into the 4-5 ppm region. Notably, the eight resonances for the innermost protons are separated into two sets of signals for mHe[2]C·8PF6 (two protons resonate at ∼5.10 ppm and six protons resonate at ∼4.25 ppm), while these same eight proton resonances in the spectrum of mHo[2]C·8PF6 are separated into four sets of signals at 5.29, 4.98, 4.38, and 4.07 ppm. These observations can be attributed to the asymmetric cavities of the mCBPQT4+ component ring(s). The encapsulated BIPY2+ unit(s) are obliged to reside closer to the p-xylylene linker end than the m-xylylene linker end in order to attenuate Coulombic repulsions as much as possible. As a consequence, the innermost protons on the BIPY2+ units of mCBPQT4+ experience different extents of shielding, leading to well separated chemical shifts. The remaining proton resonances in the spectra of mHe[2]C·8PF6 and mHo[2]C·8PF6 are also more complicated for similar reasons.
The previously reported protocol in Reference 16b uses Zn dust as the reducing agent to generate rapidly the trisradical tricationic complexes. Zn dust, however, must be removed from the reaction mixture before BIPY is added to the solution so as to react with the encapsulated xylylene dibromide. Zn will over-reduce the viologen radical cation to give its neutral state if it remains in the reaction mixture. Once the substitution is over, however, the newly formed BIPY2+ cannot be reduced because of the absence of reducing reagents in the solution. Hence, there will be fast electron exchange between the newly formed BIPY2+ units and the trisradical tricationic complexes, a situation which will reduce the formation of the trisradical tricationic complexes and therefore decrease the catenation yield. The advantage of using Cu dust is that it can remain in the reaction mixture with no threat of over-reduction, and can reduce continuously the newly formed BIPY2+ units to radical cations. Synthetic Protocols
mHeC•6PF6: mCBPQT•4PF6 (330 mg, 0.30 mmol) and 1•2PF6 (270 mg, 0.34 mmol) were dissolved in degassed MeCN (60 mL) in a 100-mL round-bottomed flask in a N2-filled glovebox. An excess of Cu dust (∼100 mg) was added with stirring to this solution. After 2 h, the solution turned from colorless to a deep purple color, an observation which is indicative of the formation of the trisradical tricationic complex. Then 4,4′-bipyridine (54 mg, 0.34 mmol) was added to it, and the resulting mixture was allowed to stand for 7 days at room temperature. Cu Dust was removed by filtration and the solvent was evaporated off under vacuum. The crude product was purified using reversed-phase flash chromatography (C18: H2O/MeCN 0.1% TFA 0-100%), followed using anion exchange from TFA- to PF6- by treating the aqueous fractions with an excess of NH4PF6, resulting in a white precipitate which was collected by centrifugation and washed with H2O several times before being dried in vacuo to afford mHe[2]C•6PF6 as a dark purple solid (170 mg, 30%). For NMR spectroscopic characterization, mHe[2]C•6PF6 (2 mg) was oxidized to mHe[2]C•8PF6 by the addition of an excess (1 mg) of NO•PF6. 1H NMR (500 MHz, CD3CN, 298 K) of mHe[2]C•8PF6: δ 9.03 (d, J= 6.6, 6 H), 8.99 (d, J= 7.0 Hz, 2H), 8.87 (d, J= 6.6 Hz, 2 H), 8.83 (d, J= 6.6 Hz, 2 H), 8.72 (d, J= 6.0 Hz, 2 H), 8.40 (s, br, 1 H), 8.34-8.32 (m, 4 H), 8.17 (d, J = 7.0 Hz, 2 H), 8.14 (s, br, 9 H), 8.06 (s, br, 2 H), 7.85 (d, J = 6.5 Hz, 2 H), 7.79 (d, J = 6.5 Hz, 4 H), 7.74 (d, J = 6.5 Hz, 2 H), 6.17-6.13 (m, 6 H), 6.00-5.96 (m, 10H), 5.09 (s, br, 2 H), 4.28-4.22 (m, 6 H). 13 C NMR (125 MHz, CD3CN, 298 K) of mHe[2]C•8PF6: δ 149.0, 148.8, 148.3, 148.0, 147.7, 147.3, 146.9, 146.6, 143.4, 143.2, 142.8, 140.4, 140.0, 138.8, 138.2, 136.9, 136.8, 135.8, 135.1, 134.7, 133.0, 132.9, 132.5, 132.0, 128.2, 128.0, 127.7, 122.9, 122.9, 122.5, 67.5, 67.2, 67.0, 65.6, 65.5, 65.4. ESI-HRMS for mHe[2]C•6PF6; Calcd for C72H64F36N8P6: m/z = 810.1905 [M- 2PF6]2+; found: 810.1889.
4•3PF6: 3•2PF6 (350 mg, 0.50 mmol) and (4-(bromomethyl)phenyl)methanol (120 mg, 0.60 mmol) were dissolved in degassed MeCN (60 mL) in a 100-mL round-bottomed flask. The solution was heated to 80° C. for 16 h with stirring. After cooling down to room temp, excess of TBAC1 was added to the solution. The solids were collected by filtration, and the crude product was purified by reversed-phase flash chromatography (C18: H2O/MeCN 0.1% TFA 0-100%), followed by anion exchange from TFA- to PF6- by treating the aqueous fractions with an excess of NH4PF6, resulting in a white precipitate which was collected by centrifugation and washed with H2O several times before being dried in vacuo to afford 4•3PF6 as an off-white solid (211 mg, 45%). 1H NMR (500 MHz, CD3CN, 298 K): δ 9.00-8.94 (m, 8 H), 8.42-8.37 (m, 8 H), 7.63-7.59 (m, 4 H), 7.59 (s, 4 H), 5.87-5.85 (m, 4 H), 5.83 (s, 2 H), 4.65 (s, 2 H). 13 C NMR (125 MHz, CD3CN, 298 K) δ 151.9, 151.4, 151.0, 146.5, 146.4, 145.2, 143.9, 134.7, 132.0, 131.6, 131.6, 131.3, 130.2, 128.44, 128.42, 128.36, 128.32, 127.4, 100.8, 65.4, 64.9, 64.8.
2•3PF6: 4•2PF6 (160 mg, 0.83 mmol) was dissolved in HBr (33% in HOAc) (10 mL) in a 25-mL vial. The solution stirred under rt for 16 before the all the solvents were removed in vacuo. The residue was dissolved in water (10 mL), and excess NH4PF6 were added to the solution. The precipitate was collected by filtration, washed with H2O for several times before being dried in vacuo to afford 2•3PF6 as an off-white solid (153 mg, 92%). 1H NMR (500 MHz, CD3CN, 298 K): δ 9.00-8.93 (m, 8 H), 8.41-8.38 (m, 8 H), 7.64-7.50 (m, 8 H), 5.85-5.84 (m, 6 H), 4.654 (s, 2 H). 13 C NMR (125 MHz, CD3CN, 298 K) δ 151.9, 151.3, 151.1, 146.5, 146.5, 145.2, 143.9, 134.7, 132.0, 131.6, 131.6, 131.3, 130.2, 128.46, 128.40, 128.35, 128.2, 127.4, 100.8, 65.4, 65.0, 63.6.
mHoC•6PF6: Following a procedure similar to that described for the synthesis of mHe [2]C•6PF6, the reaction of a mixture composed of mCBPQT•4PF6 (220 mg, 0.20 mmol), 2•3PF6 (142 mg, 0.17 mmol) afforded mHo[2]C•6PF6 as a dark purple solid (69 mg, 18%). For NMR spectroscopic characterization, mHo[2]C•6PF6 (2 mg) was oxidized to mHo[2]C•8PF6 by the addition of an excess (1 mg) of NO•PF6. 1H NMR (500 MHz, CD3CN, 298 K) of mHo[2]C·8PF6: δ 9.09 (d, J= 8.0 Hz, 2 H), 9.03-9.01 (m, 4 H), 8.98 (d, J= 7.5 Hz, 2 H), 8.82 (d, J= 6.5 Hz, 2 H), 8.76 (d, J= 6.5 Hz, 8 H), 8.42-8.32 (m, 18 H), 7.87-7.85 (m, 4 H), 7.77-7.75 (m, 4 H), 7.65-7.63 (m, 2 H), 6.20-5.97 (m, 16 H), 5.29 (s, br, 2 H), 4.98 (s, br, 2 H), 4.38 (s, br, 2 H), 4.07 (s, br, 2 H). 13C NMR (125 MHz, CD3CN, 298 K) of SC•8PF6: δ 148.3, 147.7, 147.5, 147.0, 146.6, 146.3, 143.3, 142.4, 142.2, 140.0, 138.6, 136.6, 136.3, 135.2, 134.5, 132.8, 131.9, 131.4, 131.0, 128.1, 127.9, 127.6, 127.3, 67.1, 66.4, 65.4, 65.3. ESI-HRMS for mHo[2]C•6PF6; Calcd for C72H64F36N8P6: m/z = 810.1905 [M- 2PF6]2+; found: 810.1895.
Single crystals of the two catenanes were grown under ambient conditions by slowly evaporating Et2O into 1.0 mM MeCN solutions over a week which affords dark red crystals suitable for X-ray crystallographic analysis. The solid-state structures show (
Since the stabilities of viologen radicals in air are mainly determined by their potentials, the redox properties of mHe[2]C·6PF6 and mHo[2]C·6PF6 were investigated by cyclic voltammetry (CV). The CV curve for mHe[2]C·6PF6 exhibits (
Significantly, the potentials of the second reduction peaks of mHe[2]C8+ (Ered2 = +0.29 V) and mHo[2]C8+ (Ered2 = +0.34 V) are comparable to the first reduction potentials of TEMV2+ (Ered1 = +0.29 V,
In order to gain additional insight into their electronic properties, we recorded the UV-Vis-NIR spectra of the two [2]catenanes in their various electrochemically generated redox states at different potentials. The CV traces (
We also examined the stabilities of the tetra-, bis-, and monoradical states of the two [2]catenanes in air by time-dependent UV-Vis-NIR spectroscopy under ambient conditions. Upon exposure to air, the tetraradicals (mHe[2]C4(•+) and mHo[2]C4(•+)) in MeCN were observed (
Organic NIR dyes with absorption bands longer than 1200 nm are not abundant3b,21, not only because such red-shifted absorptions are difficult to achieve, but also because organic compounds with extremely narrow bandgaps suffer from stability issues. Hence, our results show that, the mono- and bisradical states of these two [2]catenanes are promising air-stable NIR-absorbing dyes with significantly red-shifted absorption peaks of ca. 1800 and 1450 nm.
The solution of two catenanes with different redox states were prepared by employing electrochemical reductions under different potentials: mHe[2]C•6PF6 (6.3 mg) was dissolved in MeCN (30 mL) in a N2-filled glovebox. The solution was then added into the working cell, while the auxiliary electrode chamber was filled with excess of CuPF6(MeCN)4 dissolved in 0.1 M TBAPF6/MeCN solution (1 mL). The auxiliary electrode was made with a platinum wire wrapped with copper wire (diam. 0.25 mm, 99.999% trace metals basis from Sigma Aldrich). The whole apparatus was subjected to different potentials of -0.50, +0.10, and +0.42 V (vs Ag/AgCl), respectively. After retaining the each potentials for 10 min, 1 mL of each solution was drawn out from the working cell corresponding to +4, +6, and +7 states of mHe[2]C•nPF6 respectively. Each of the three solutions was injected into a 2-mm path cuvette which sealed by Teflon caps and then was analyzed by using Vis/NIR spectroscopy. For mHe[2]C·nPF6, the +4, +6, and +7 states were obtained using the same protocol under the potentials of -0.50, +0.10, and +0.50 V, respectively. The +6 states (bisradical hexacationic states) of mHo[2]C·nPF6 and mHe[2]C·nPF6 were exposed to air for several days and the Vis/NIR spectra were recorded to test their air-stability.
We also recorded (
DFT calculations were performed in order to probe the electronic properties of the two catenanes. The results illustrate (
Calculations were performed using density functional theory (DFT) with the M06 functional, as implementedS5 in Jaguar 7.6.110. Geometry optimizations were performedS6 using the 6-31G* basis set. Electronic energies (Table 1) were obtainedS7 using the 6-311++G** basis set. ΔE is the difference in energy between the sum of the individual macrocycles of a particular change state and the corresponding [2]catenane of charge (8-n)·n+. Association energy differences (ΔΔE) detween different charged dtates are shown in Table 2. Solvent corrections were based on single point self-consistent Poisson-Boltzmann continuum solvation calculations for MeCN (ε = 37.5 and R0= 2.179 Å) usingS8 the PBF module in Jaguar.
aΔΔE = ΔE7+-ΔE8+; bΔΔE = ΔE6+-ΔE8+
The present application claims benefit of priority to United States Application Ser. No. 62/994,778, filed Mar. 25, 2020, the contents of which is incorporated by reference in its entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2021/024169 | 3/25/2021 | WO |
Number | Date | Country | |
---|---|---|---|
62994778 | Mar 2020 | US |